Scientific Sessions

Dr. Todd BullNew Treatments and Targets in Pulmonary Hypertension
June 19 - 20, 2014

At the Scientific Sessions at PHA’s International PH Conference, researchers and medical professionals will have the opportunity to engage in educational sessions about PH practice and cutting-edge research. This year’s topic, New Treatments and Targets in Pulmonary Hypertension, features PH experts who will share the latest developments in PH treatment and research. The Scientific Sessions will also feature a presentation of abstract posters and free-form panel discussions about the top abstracts.

Learning Objectives

After participating in this activity, participants will be able to:

  • Discuss future drug targets in Group I and COPD-associated pulmonary hypertension.
  • Discuss limitations of current trial designs in pulmonary arterial hypertension.
  • Describe future treatment of BMPR2 mutation in pulmonary arterial hypertension.

Scientific Sessions Schedule and Speakers

Scientific Sessions Poster Hall Reception
Thursday, June 19, 5:30-7:30 p.m.

Join your colleagues to view abstracts in the poster hall.

Scientific Sessions: New Treatments and Targets in PH
Friday, June 20, 8 a.m. - 7:30 p.m.

High Throughput Drug Screening in PAH: From Cells to People
Edda Spiekerkoetter, MD, Stanford University, Stanford, Calif. 
Roham Zamanian, MD, FCCP, Stanford University, Stanford, Calif. 

NOS Inhibition in COPD – Potential Therapeutics for Group III PH?
Norbert Weissmann, PhD, University of Giessen, Giessen, Germany

Nitric Oxide Therapeutics in Pulmonary Vascular Disease
Marc Simon, MD, MS, FACC, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Clinical Trial Design in Pulmonary Vascular Disease in Adults – Panel Discussion
Panelists will include: 

Richard Channick, MD, Massachusetts General Hospital, Boston, Mass.
Tim Moore, MD, PhD, NHLBI, Bethesda, Md. 
Mardi Gomberg-Maitland, MD, MSc, University of Chicago, Chicago, Ill.

Metabolic Derangements in PH – Dichloracetate Studies
Evangelos Michelakis, MD, University of Alberta, Edmonton, Canada

Trials in Pediatric PH: Specific Concerns in Design and Endpoints
Dunbar Ivy, MD, Children’s Hospital Colorado, Aurora, Colo.

Future Therapies in PAH – Update on the New Landscape and Drugs in the Pipeline
Ioana Preston, MD, Tufts-New England Medical Center, Boston, Mass.

Conference Alerts

Sign up now

2012 Highlights

Check out video highlights from our 2012 Conference and get an up-close view on the education, networking and fun that took place.

View 2012 Conference Highlights

PHA thanks the sponsors of the International PH Conference and Scientific Sessions!

Diamond Sponsors: Actelion Bayer Gilead

Platinum Sponsor: United Therapeutics

Silver Sponsor: Lung Biotechnology

Bronze Sponsor: Accredo

General Sponsor: Reata Pharmacueticals CVS Caremark Specialty PharmacySteadyMed Therapeutics, Inc.Nora Thelma Bostrom Foundation

To support the International PH Conference and Scientific Sessions, please visit the sponsorship page.


For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.